Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada and the state of Utah, United States. Its properties include Jubilee Mountain, Falcon and Paradox Basin. It owns a 100% interest in two barium sulphate (barite) projects, including the Frances Creek and Pedley Mountain property. It holds interests in a high-grade iodine, lithium, and bromine brine project situated in Utah, United States. It owns a 100% interest in two battery mineral projects that is focused on copper/zinc development. Its pipeline products include SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101 and VY-103.


TSXV:VM - Post by User

Comment by BoracayGuyon Jan 17, 2019 8:01pm
119 Views
Post# 29248911

RE:RE:New direction

RE:RE:New directionYakpi.  This is not a high tonnage play or market in fact. Ive looked at this, the processing is actually quite simple, after powering it perhaps a simple acid wash HCL & Sulfaric at minimal % and its near if not  at USB grade.  Must remember the grade and and purity going into the plant matters - the higher the better. if you look at their core intercepts many are near pharma grade (97.5%) in-situ - pre-processing.  

The feasability study will answer all these questions.  They've retained SGS Canada.  I'm waiting for that, but its a sleeper that I think will surprize in terms of creating and selling a real commercial product.   

But your point rerlates to Market size: 1000 tonnes/year, 2500 tonnes /year... seems puny doesnt it.  I challenge you to look into this with respect to their core offering Barium Sulfate for the pharma barium contrast market. Your going to be suprized how valuabe the barite becomes once maufactured into barium contrast for the radiology sector (used primarily in x-ray applications).  Moreover, how low (consumption) tonnage of a market this is...       
Bullboard Posts